SNCA and Parkinson disease: Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are synucleinopathies characterized by the oligomerization and aggregation of α-synuclein into assemblies rich in cross-beta structure, which is a critical event in the pathogenesis of these diseases1–6.